anthony holler  crh medical corporation  zoominfocom   insider trading  holler anthony f  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  holler anthony f select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing option award  pm nana response biomedical corp rbm holler anthony fdirector   direct view disposition  pm nana response biomedical corp rbm holler anthony fdirector   direct view disposition  pm na response biomedical corp rbm holler anthony fdirector   direct view disposition  pm na response biomedical corp rbm holler anthony fdirector   direct view disposition  pm na response biomedical corp rbm holler anthony fdirector   direct view disposition  pm na response biomedical corp rbm holler anthony fdirector   direct view option award  pm nana response biomedical corp rbm holler anthony fdirector   direct view disposition  pm na response biomedical corp rbm holler anthony fdirector   direct view option award  pm nana response biomedical corp rbm holler anthony fdirector   direct view option award  pm na response biomedical corp rbm holler anthony fdirector   direct view option award  pm nana response biomedical corp rbm holler anthony fdirector   direct view option award  pm nana response biomedical corp rbm holler anthony finterim ceodirector   direct view option award  pm na response biomedical corp rbm holler anthony finterim ceodirector   direct view   secformcom all rights reserved archives        fri  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  anthony f holler chmn corriente resources inc a publisher of business information since         search business search executive   advanced search   sign in    hints profile of anthony holler   anthony holler   chmn  corriente resources inc   anthony holler email  please login   company name  corriente resources inc   company website  wwwcorrientecom   company address   w pender st vancouver bccanada   anthony holler profile  chmn  corriente resources inc   anthony holler biography  mr holler was formerly the chief executive officer and a founder of id biomedical corporation and joined the corriente board of directors in  dr holler held a number of executive positions with idb an integrated biotechnology company dedicated to the development of innovative vaccine products which operates in research development manufacturing sales and marketing from its facilities in canada and in the united states after becoming ceo of id biomedical the company grew from a market capitalization of approximately  million to  billion which was equal to the company’s takeover value paid by glaxo smith klein prior to founding idb dr holler served as an emergency room physician at university hospital at the university of british columbia he is a member of the british columbia college of physicians and surgeons   anthony holler colleagues  name title email kenneth shannon dir ceo please login thomas milner pres please login daniel carriere sr vp please login darryl jones cfo corp sec please login richard clark board dir please login             home    about us    product information     subscription    list builder     executive list     email lists     contact us    site map    browse directory        walkerss research  a publisher of business information since  all rights reserved dr anthony f holler  director for response biomedical corp rpbif from the makers of track  manage all of your investments try it now new portfolio       login  sign up search industriestechnologyenergymediafinancegreen issueschinaall conceptsmetalsenergymeatsgrainssoftsetfsindicescurrenciesgeographiesexchangesrateshow to investpersonal financeoptions definitions response biomedical corp rpbif     summarybullsbearstopicsdata centralstock chartsec filingsbalanceincomecash flowrpbif » topics » dr anthony f holler  directorthis excerpt taken from the rpbif f filed mar  dr anthony f holler  director dr holler has served as one of our directors since march  dr holler was one of the original founders of id biomedical corporation in  and was a member of its board of directors since inception he held a number of executive positions with id biomedical including president and chief executive officer until glaxosmithkline acquired the company in december  prior to founding id biomedical dr holler served as an emergency physician at university hospital at the university of british columbia he is a member of the british columbia college of physicians and surgeons dr holler also serves as chairman of the board of crh medical corporation formerly medsurge medical products corporation and is a director of corriente resources inc dr holler holds a bachelor of science degree and a medical degree from the university of british columbia  this excerpt taken from the rpbif f filed jun  dr anthony f holler  director dr holler has served as one of our directors since march  dr holler was one of the original founders of id biomedical corporation in  and was a member of its board of directors since inception he held a number of executive positions with id biomedical including president and chief executive officer until the company was acquired by glaxosmithkline in december  prior to founding id biomedical dr holler served as an emergency physician at university hospital at the university of british columbia he is a member of the british columbia college of physicians and surgeons dr holler also serves as chairman of the board of crh medical corporation formerly medsurge medical products corporation and is a director of corriente resources inc excerpts on this pagefmar  fjun  related topics for rpbifrichard bastiani phd director chairman boardtodd patrick directorbrian richards peng director chief operating officer corporateview more skip the spreadsheet track your investments automatically start now wikinvest         use of this site is subject to express terms of service privacy policy and disclaimer by continuing past this page you agree to abide by these terms any information provided by wikinvest including but not limited to company data competitors business analysis market share sales revenues and other operating metrics earnings call analysis conference call transcripts industry information or price targets should not be construed as research trading tips or recommendations or investment advice and is provided with no warrants as to its accuracy stock market data including us and international equity symbols stock quotes share prices earnings ratios and other fundamental data is provided by data partners stock market quotes delayed at least  minutes for nasdaq  mins for nyse and amex market data by xignite see data providers for more details company names products services and branding cited herein may be trademarks or registered trademarks of their respective owners the use of trademarks or service marks of another is not a representation that the other is affiliated with sponsors is sponsored by endorses or is endorsed by wikinvest about  blog  press  feedback  help  get involvedmobile  advertise  licensing  partnerships  blogger tools  jobs microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft anthony f holler md executive profile  biography  bloomberg july    pm et healthcare equipment and supplies company overview of inviro medical snapshotpeople  overviewboard memberscommittees executive profile anthony f holler mdchairman chief executive officer and president inviro medicalagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationships background dr anthony f holler also known as tony md serves as the chief executive officer and president at inviro medical dr holler served as treasurer at response biomedical corp until january   and served as its interim chief executive officer from september   until may   he previously served as the chief financial officer at response biomedical corp dr holler served as chairman and interim chief executive officer of inviro medical devices limited  dr holler served as chief executive officer at id biomedical corp from march   to december  and also served as its president dr holler has been the independent chairman of crh medical corporation since december   he has been chairman of inviro medical since august  and trevali resources corp since october  he serves as nonexecutive chairman of q gold resources inc and its director since june   he served as the chairman of trevali mining corporation from october  to february   dr holler served as nonexecutive chairman of corriente resources inc from  to june  he served as vicechairman of response biomedical corp since november  until november   he serves as a member of advisory board of roadmap capital inc dr holler has been an independent director of crh medical corporation since december   and inviro medical since april   he served as a director of response biomedical corp since march   until november   he served as a director of neptune technologies  bioressources inc since july   he served as a director of corriente resources inc since september   dr holler served as a director of id biomedical corporation since march   he served as an emergency physician at university hospital at university of british columbia dr holler is a member of the british columbia college of physicians and surgeons he holds a bachelor of science in  and a medical degree in  from the university of british columbiaread full background corporate headquarters  north brown roadlawrenceville georgia united statesphone fax  board members memberships presentindependent chairmancrh medical corporationpresentchairman chief executive officer and presidentinviro medicalpresentnon executive chairmanq gold resources inc education bs university of british columbiamd university of british columbia other affiliations id biomedical corporationcorriente resources incresponse biomedical corpneptune technologies  bioressources incuniversity of british columbiacrh medical corporationtrevali mining corporationq gold resources incinviro medical devices limitedroadmap capital inc annual compensation there is no annual compensation data available stocks options there is no stock options data available total compensation there is no total compensation data available request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact inviro medical please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close board of directors  crh medical corporation board of directors board of directors management team corporate governance careers about us contact us crh medical board of directors composed of accomplished physicians and business leaders our board of directors is focused on building a company with exceptional medical impact – and ongoing financial success   dr anthony f holler  chairman of the board dr holler has served as one of our directors since december  dr holler was one of the original founders of id biomedical corporation in  and was a member of its board of directors since inception he held a number of executive positions with id biomedical including chief executive officer until the company was acquired by glaxosmithkline in december  prior to founding id biomedical dr holler served as an emergency physician at university hospital at the university of british columbia he is a member of the british columbia college of physicians and surgeons dr holler holds a bachelor of science degree and a medical degree from the university of british columbia member of audit committee corporate governance  nominating committee compensation committee david a johnson md facp facg fasge  director dr johnson has been a director of the company since june of  and is a partner of gastrointestinal and liver specialists of tidewater pllc in norfolk va since  dr johnson was one of the founding members of crh’s scientific advisory board he is boardcertified in internal medicine and gastroenterology and is a past president as well as a master of the american college of gastroenterology dr johnson currently serves as professor of medicine chief of gastroenterology in eastern virginia medical school he has authored more than  papers in the field of gastroenterology todd patrick  director mr patrick is the president and chief executive officer of cj therapeutics inc a clinical stage biotechnology company based in los angeles california prior to joining cj mr patrick was the president and chief operating officer of id biomedical corporation mr patrick was with id biomedical from  until  when the company was acquired by glaxosmithkline prior to id biomedical mr patrick was the director of the office of intellectual property administration at the university of california los angeles ucla where he was responsible for the patenting and licensing of intellectual property arising out of ucla mr patrick holds a ba economics from the university of washington and a master’s in business administration from washington state university mr patrick has been a director of the company since may  member of audit committee corporate governance  nominating committee compensation committee ian webb  director mr webb has been a director of the company since may  he was admitted to the british columbia bar in  after graduating from osgoode hall law school at york university with a bachelor of laws in  prior to that mr webb received a master of science in theoretical physics from the university of saskatchewan in  mr webb practiced in the areas of corporate and securities law with an emphasis on the legal requirements of public companies he is a retired partner of the law firm borden ladner gervais llp member of audit committee corporate governance  nominating committee compensation committee edward wright  chief executive officer director mr wright became ceo and director of the company in september of  prior to joining crh he gained extensive management experience in global luxury brands at richemont the holding company for some of the world’s leading luxury goods as president of baume  mercier first and then as executive vicepresident of north america retail for cartier mr wright developed an ability for building solid relationships with customers and business partners alike upon arriving at crh mr wright was tasked with maximizing the value of crh’s o’regan system he quickly determined that crh needed to transition from a retail model to a wholesale model and by introducing it to the gastrointestinal “gi” community in the us he created a paradigm shift for gastrointestinal doctors “gis” by extending their continuum of care for patients to maximize the value of crh mr wright leveraged our relationships with the gi community leading to the launch of crh anesthesia management a business focused on providing gi anesthesia services to ambulatory surgical centers “ascs” across the us crh anesthesia is now the primary driver of the company’s revenue and is positioned as one of the leading gi anesthesia brands in the us with outstanding growth potential under mr wright’s management crh has become a profitable company with strong cash flow generation and access to north american capital markets to fund the company’s longterm growth strategy mr wright is a member of the young presidents’ organization and chair of vancouver college’s board of directors back to topˆ were a stable profitable company respected by both patients and physicians learn more » corriente resources inc  corporate  management  dr anthony tony holler corporate overview history management directors corporate governance directory news current news news archives technical reports disclosure statements copper assets investors financial reports latest presentation analyst coverage share capital contact contact careers home kenneth r shannon daniel a carriere darryl f jones kenneth r shannon richard p clark anthony holler g ross mcdonald dale c peniuk david g unruh dr anthony tony holler md director  chairman mr holler was formerly the chief executive officer and a founder of id biomedical corporation and joined the corriente board of directors in  dr holler held a number of executive positions with idb an integrated biotechnology company dedicated to the development of innovative vaccine products which operates in research development manufacturing sales and marketing from its facilities in canada and in the united states after becoming ceo of id biomedical the company grew from a market capitalization of approximately  million to  billion which was equal to the company’s takeover value paid by glaxo smith kline prior to founding idb dr holler served as an emergency room physician at university hospital at the university of british columbia currently he is a member of the british columbia college of physicians and surgeons dr holler is also the chairman of crh medical corporation a director of response biomedical corp and the chairman of inviro medical    corriente resources incdisclaimer board of directors  crh medical corporation board of directors board of directors management team corporate governance careers about us contact us crh medical board of directors composed of accomplished physicians and business leaders our board of directors is focused on building a company with exceptional medical impact – and ongoing financial success   dr anthony f holler  chairman of the board dr holler has served as one of our directors since december  dr holler was one of the original founders of id biomedical corporation in  and was a member of its board of directors since inception he held a number of executive positions with id biomedical including chief executive officer until the company was acquired by glaxosmithkline in december  prior to founding id biomedical dr holler served as an emergency physician at university hospital at the university of british columbia he is a member of the british columbia college of physicians and surgeons dr holler holds a bachelor of science degree and a medical degree from the university of british columbia member of audit committee corporate governance  nominating committee compensation committee david a johnson md facp facg fasge  director dr johnson has been a director of the company since june of  and is a partner of gastrointestinal and liver specialists of tidewater pllc in norfolk va since  dr johnson was one of the founding members of crh’s scientific advisory board he is boardcertified in internal medicine and gastroenterology and is a past president as well as a master of the american college of gastroenterology dr johnson currently serves as professor of medicine chief of gastroenterology in eastern virginia medical school he has authored more than  papers in the field of gastroenterology todd patrick  director mr patrick is the president and chief executive officer of cj therapeutics inc a clinical stage biotechnology company based in los angeles california prior to joining cj mr patrick was the president and chief operating officer of id biomedical corporation mr patrick was with id biomedical from  until  when the company was acquired by glaxosmithkline prior to id biomedical mr patrick was the director of the office of intellectual property administration at the university of california los angeles ucla where he was responsible for the patenting and licensing of intellectual property arising out of ucla mr patrick holds a ba economics from the university of washington and a master’s in business administration from washington state university mr patrick has been a director of the company since may  member of audit committee corporate governance  nominating committee compensation committee ian webb  director mr webb has been a director of the company since may  he was admitted to the british columbia bar in  after graduating from osgoode hall law school at york university with a bachelor of laws in  prior to that mr webb received a master of science in theoretical physics from the university of saskatchewan in  mr webb practiced in the areas of corporate and securities law with an emphasis on the legal requirements of public companies he is a retired partner of the law firm borden ladner gervais llp member of audit committee corporate governance  nominating committee compensation committee edward wright  chief executive officer director mr wright became ceo and director of the company in september of  prior to joining crh he gained extensive management experience in global luxury brands at richemont the holding company for some of the world’s leading luxury goods as president of baume  mercier first and then as executive vicepresident of north america retail for cartier mr wright developed an ability for building solid relationships with customers and business partners alike upon arriving at crh mr wright was tasked with maximizing the value of crh’s o’regan system he quickly determined that crh needed to transition from a retail model to a wholesale model and by introducing it to the gastrointestinal “gi” community in the us he created a paradigm shift for gastrointestinal doctors “gis” by extending their continuum of care for patients to maximize the value of crh mr wright leveraged our relationships with the gi community leading to the launch of crh anesthesia management a business focused on providing gi anesthesia services to ambulatory surgical centers “ascs” across the us crh anesthesia is now the primary driver of the company’s revenue and is positioned as one of the leading gi anesthesia brands in the us with outstanding growth potential under mr wright’s management crh has become a profitable company with strong cash flow generation and access to north american capital markets to fund the company’s longterm growth strategy mr wright is a member of the young presidents’ organization and chair of vancouver college’s board of directors back to topˆ were a stable profitable company respected by both patients and physicians learn more »